| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702379 | Surgical Oncology | 2017 | 8 Pages |
Abstract
Our results suggest that IL16 rs7170924-GG and IL12A rs662959-TT genotypes predict higher risk of death and progression, respectively, in NSCLC patients. No influence of IL1B rs12621220, IL1B rs1143623, IL1B rs16944, IL1B rs1143627, IL6 rs1800795, IL13 rs1881457 on NSCLC clinical outcomes was found in our patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Cristina Pérez-RamÃrez, Marisa Cañadas-Garre, Ahmed Alnatsha, Miguel Ángel Molina, Ana I. Robles, Eduardo Villar, Juan Ramón Delgado, MarÃa José Faus-Dáder, Miguel Ángel Calleja-Hernández,